Twin Health
Buying intent
32 tracked signals | Top 15 topics are below | Marketing and HR are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Twin Health's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
16d ago
16d ago
15d ago
24d ago
23d ago
30d ago
16d ago
20d ago
18d ago
20d ago
17d ago
19d ago
9d ago
9d ago
9d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Twin Health
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileTwin Health combines advanced medical science and technology with a clinical care team to help people take control of conditions like type 2 diabetes, prediabetes, and obesity. Twin is a metabolic health benefit offered exclusively through employers or health plans. Our Digital Twin™ technology learns a member’s unique metabolism based on insights collected from smart devices, meal logs, and lab
Top accounts researching Twin Health
names withheld on the public pageThese are companies whose own people brought up Twin Health unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
1,900 companies · 6,134 people are researching Digital Twin
Twin Health's own team shows 12 signals on this topic. No one outside Twin Health has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Artificial Intelligence151,426 cos · 839,012 people
- Hiring75,708 cos · 411,263 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Marketing — 4 people; Leadership — 1 person; HR / Talent — 1 person
What's been said
public posts mentioning Twin HealthUp to 9 public excerpts naming Twin Health from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
I don’t think employers need another GLP-1 access strategy. They need a GLP-1 outcomes strategy. That’s a distinction we think about a lot at Twin Health. GLP-1s can be an important tool in care. But utilization isn’t an outcome. If the business model benefits from continued prescription utilization, where is the incentive to help a member reduce or come off medication when it’s clinically appropriate? The point is that the clinical outcome, not continued utilization, should determine success. A successful strategy should be able to answer harder questions: Are members getting healthier? Is that improvement durable? Are medications being used for the right people, for the right amount of time? At Twin, that means looking beyond the prescription. Our Digital Twin Care Platform uses each member’s health data to guide care in the moment, helping members improve their metabolic health while their clinical team can adjust treatment (including medications), based on how their health is actually changing. That's what our four core programs are built to do, whether or not a GLP-1 is part of the picture: meet each member where they are, and keep them progressing before, during, and after any medication. GLP-1s can be part of that strategy. They just shouldn't be the strategy. That's where I think the conversation needs to go next: from who gets access to what that access actually achieves. What is your GLP-1 vendor incentivized to achieve?
Sep 2026